Pediatric Hematology/Oncology Seminar and Workshops Announced

Publication
Article
OncologyONCOLOGY Vol 12 No 10
Volume 12
Issue 10

Advances in Pediatric Hematology/Oncology will be held November 19 through 21, 1998, at the Hilton Clearwater Beach Resort, Florida (formerly the DoubleTree). Topics presented by nationally renowned speakers include:

Advances in Pediatric Hematology/Oncology will be held November 19 through 21, 1998, at the Hilton Clearwater Beach Resort, Florida (formerly the DoubleTree). Topics presented by nationally renowned speakers include:

  • Transplantation

  • Pain management

  • Sickle cell disease

  • Immune tolerance/inhibitors

  • HIV-related malignancy

  • Pathology, new cancer agents

  • Supportive care

Representatives of various organizations will display the latest in supplies, products, and services.

Early registration fees are $130 and $50 for full-time students/residents (with accompanying letter from a faculty advisor). Please inquire about late registration fees and single-day rates.

Workshops will be held Saturday, November 21, on the topics of medical Spanish (prerequisite, knowledge of conversational Spanish) and alternative therapies for pediatric patients.

For registration forms or sponsorship opportunities please contact: The Florida Association of Pediatric Tumor Programs, P. O. Box 17757, Tampa, FL 33682-7757; phone: (813) 632-1309; e-mail: FAPTP@moffit.usf.edu.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Approximately 10% of patients discontinued treatment with avutometinib/defactinib due to toxicity in the phase 2 RAMP 201 trial.
Response rates appeared to be higher with avutometinib plus defactinib vs avutometinib alone in the phase 2 RAMP 201 study.
Patients who respond to avutometinib/defactinib may be maintained on treatment for long periods of time, says Rachel N. Grisham, MD.
Related Content